文献速递骨肿瘤关节外科

骨水泥型股骨远端肿瘤假体10年生存率及与无菌性松动相关的影像学特征

What Is the 10-year Survivorship of Cemented Distal Femoral Endoprostheses for Tumor Reconstructions and What Radiographic Features Are Associated with Survival?
PubMed 文献 · Clin Orthop Relat Res · 2020-01-01

多中心回顾性研究纳入195例骨水泥型股骨远端肿瘤假体置换患者,中位随访78个月,5年和10年无无菌性松动生存率分别为95%和93%,10年全因生存率64%;初步观察发现无皮质外重塑且交界区透亮区超过股骨柄全长20%者均出现无菌性松动。

要点

  • 骨水泥型股骨远端肿瘤假体10年无无菌性松动生存率93%,全因生存率64%。
  • 交界区透亮区超过股骨柄全长20%且无皮质外重塑者均发生无菌性松动。
  • 出现进行性透亮区及疼痛症状时可考虑密切影像学监测和翻修手术。

核心结论

  • 骨水泥型股骨远端肿瘤假体无菌性松动率相对较低,第一个十年生存率可接受。
  • 交界区透亮区超过股骨柄全长20%且无皮质外重塑可能与无菌性松动相关,但需未来研究验证。

研究设计与样本

  • 多中心回顾性研究,1997年至2017年五家机构共246例患者符合初始纳入标准,排除21%(51例)随访不足2年者,最终195例纳入分析。
  • 平均随访78个月(范围22至257个月),分析时69%(135/195)患者存活。

主要发现

  • 5年和10年无无菌性松动生存率分别为95%(95% CI 89至98)和93%(95% CI 86至97)。
  • 5年和10年全因无翻修生存率分别为74%(95% CI 65至79)和64%(95% CI 49至70)。
  • 所有无菌性松动患者均存在交界区透亮区超过股骨柄全长20%且股骨柄尖端无皮质外重塑。
  • 若存在皮质外重塑、交界区透亮区小于20%或使用直径≥13 mm的弯曲股骨柄,则未观察到无菌性松动。

关键数值与推荐

  • 无菌性松动影像学定义为所有视图上出现环形透亮线,或股骨柄周围下沉且无感染证据。
  • 交界区透亮区定义为从骨-假体交界处延伸至股骨柄尖端的透亮区。
  • 皮质外重塑定义为股骨柄尖端皮质厚度增加。

临床怎么用

  • 对于骨水泥型股骨远端肿瘤假体,建议密切影像学监测进行性透亮区和临床疼痛症状。
  • 若考虑翻修,推荐使用较大直径的弯曲骨水泥型股骨柄。

局限性

  • 仅9例患者发生无菌性松动,样本量不足以进行统计学分析,影像学特征仅为初步定性观察。
  • 21%(51例)患者随访不足2年被排除,可能引入选择偏倚。
  • 研究为回顾性设计,证据等级为III级治疗性研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Aseptic loosening is one of the most common causes of revision of distal femoral endoprostheses and is considered a mid- to long-term complication. There are not many reports of 10-year survivorship free from aseptic loosening and all-cause survivorship in cemented stems. To our knowledge, there are no reports on radiographic features that are associated with aseptic loosening of these implants. QUESTIONS/PURPOSES: (1) What is the 5- and 10-year survivorship free from aseptic loosening in patients undergoing reconstruction with a cemented distal femoral endoprosthesis after a tumor resection? (2) What is the all-cause 5- and 10-year survivorship at in these patients? (3) What radiographic features are associated with aseptic loosening at long-term follow-up? METHODS: We performed a multicenter retrospective study reviewing aseptic loosening in cemented prostheses to determine radiographic features associated with long-term implant survivorship. Patients who underwent a cemented distal femoral reconstruction with a modular endoprosthesis after resection of a musculoskeletal tumor between 1997 and 2017 were reviewed. A total of 246 patients were identified from five institutions and met initial inclusion criteria. Of those, 21% (51) were lost to follow-up before 2 years, leaving 195 patients available for us to evaluate and analyze the survivorship and radiologic features associated with long-term implant survival. The mean (range) follow-up was 78 months (22 to 257). At the time of this analysis, 69% (135 of 195) of the patients were alive. Osteosarcoma was the most common diagnosis in 43% of patients (83 of 195), followed by metastatic carcinoma 13% (25 of 195). Fifty-six percent (110 of 195) of patients received chemotherapy; 15% (30 of 195) had radiation therapy. Aseptic loosening was diagnosed radiographically and was defined as a circumferential radiolucent line on all views, or subsidence around the stem in the absence of infection. We present 5- and 10-year Kaplan-Meier survivorship free from aseptic loosening, 5- and 10-year all-cause survivorship, and a qualitative assessment of radiographic features potentially associated with aseptic loosening (including the junctional radiolucent area, and cortical expansion remodeling). The junctional radiolucent area was defined as a radiolucent area of the bone starting at the bone-endoprosthesis junction to the tip of the femoral stem, and cortical expansion remodeling was defined as an increased cortical thickness at the stem tip. Although we wished to statistically analyze radiographic factors potentially associated with aseptic loosening, we did not have enough clinical material to do so (only nine patients developed loosening). Instead, we will report a few preliminary qualitative observations, which necessarily are preliminary, and which will need to be confirmed or refuted by future studies. We urge caution in interpreting these findings because of the very small numbers involved. RESULTS: Kaplan-Meier survivorship free from aseptic loosening of the femoral component at 5 and 10 years were 95% (95% CI 89 to 98) and 93% (95% CI 86 to 97), respectively. Kaplan-Meier survivorship free from revision for any cause at 5 and 10 years were 74% (95% CI 65 to 79) and 64% (95% CI 49 to 70), respectively. Although the numbers were too small to analyze statistically, all patients with aseptic loosening had a junctional radiolucent area more than 20% of the total length of the stem without cortical expansion remodeling at the stem tip. No aseptic loosening was observed if there was cortical ex remodeling, a junctional radiolucent area less than 20%, or curved stems that were 13 mm or greater in diameter. The numbers of patients with aseptic loosening in this series were too small to analyze statistically. CONCLUSIONS: Cemented distal femoral endoprostheses have a relatively low rate of aseptic loosening and acceptable projected first-decade survivorship. The presence of a radiolucent area more than 20% without cortical expansion remodeling at the stem tip may lead to aseptic loosening in patients with these implants. Close radiographic surveillance and revision surgery may be considered for progressive lucencies and clinical symptoms of pain. If revision is contemplated, we recommend using larger diameter curved cemented stems. These are preliminary and provisional observations based on a low number of patients with aseptic loosening; future studies with greater numbers of patients are needed to validate or refute these findings. LEVEL OF EVIDENCE: Level III, therapeutic study.

来源:Clin Orthop Relat Res,查看原文。版权归原作者所有。

引用

  1. Piakong P, Kiatisevi P, Yau R, et al. What Is the 10-year Survivorship of Cemented Distal Femoral Endoprostheses for Tumor Reconstructions and What Radiographic Features Are Associated with Survival? Clin Orthop Relat Res. 2020. PMID: 32469487. doi:10.1097/CORR.0000000000001336

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。